Business Context and Reporting Period
Empire Petroleum Corporation (NYSE American: EP) filed a Current Report on Form 8-K dated September 24, 2025. The filing details the entry into a material definitive agreement involving a new debt instrument to fund ongoing oil and gas drilling programs and working capital needs.
Key Financial Metrics and Transaction Details
- Debt Instrument: Promissory Note with an aggregate principal amount of $4,000,000.
- Initial Funding: $2,000,000 advanced as of September 25, 2025.
- Commitment: Up to an additional $2,000,000 available from March 23, 2026, for a six-month period, subject to no Event of Default.
- Interest Rate: 5.5% per annum; increases to 9% per annum post-maturity.
- Maturity Date: September 23, 2027.
- Conversion Terms: Convertible at $4.27 per share (based on 5-day VWAP). Full conversion of the $4,000,000 principal would issue 936,768 shares.
- Warrant Issuance: Warrant to purchase 281,030 shares at $4.27 per share, exercisable for three years upon NYSE American supplemental listing approval.
- Liquidity Impact: Proceeds designated for drilling operations and working capital.
Material Changes and Unusual Items
This filing represents a new direct financial obligation not present in prior periods. The transaction includes a contingent origination fee of $50,000 payable in cash if NYSE American listing approval for the underlying shares and warrant shares is not received within 60 days of the original issue date. The filing references material relationships between the Company and the lender, Phil E. Mulacek, detailed in prior filings (2025 Proxy, June 2025 8-K, and Q2 2025 10-Q).
Guidance, Outlook, and Risks
Management intends to use the proceeds to support its drilling program. The transaction carries dilution risk if the note is converted or warrants are exercised. A key contingency is the requirement for NYSE American supplemental listing approval (SLAP Approval) to make the warrant exercisable; failure to obtain this within 60 days triggers the option for the lender to demand a $50,000 cash fee instead of the warrant. The filing does not provide specific revenue or profit guidance beyond the use of proceeds.
Investor Verification Checklist
- Verify the status of the NYSE American supplemental listing application for the 936,768 underlying shares and 281,030 warrant shares.
- Review the Company's 2025 Proxy Statement and Q2 2025 10-Q for details on the material relationship with Phil E. Mulacek.
- Monitor the Company's cash position to ensure it can meet the $50,000 origination fee contingency if listing approval is delayed beyond 60 days.
- Assess the dilution impact of the potential issuance of approximately 1.2 million shares (principal conversion plus warrants) relative to current outstanding shares.